Table 2.
Baseline Characteristics of Ischemic Stroke Patients with exposure to ILI
| Variable | Ischemic stroke cases with exposure to ILI N = 554 | Ischemic stroke cases without ILI N = 39421 |
|---|---|---|
| Age (years) | 74 | 71 |
| Standard deviation(range) | 13.9 (0–101) | 14.7 (0–104) |
| Number of Chronic Conditions | 8.1 | 6.2 |
| Standard deviation(range) | 3.4 (1–21) | 2.6 (1–22) |
| Length of stay(days) | 9.8 | 4.6 |
| Standard deviation(range) | 15.8 (0–351) | 7.7 (0–345) |
| Women, No. (%) | 313 (56.5%) | 20, 538 (52.1%) |
| Race No. (%) | ||
| White | 311 (56.1%) | 23,889 (60.6%) |
| Black | 69 (12.4%) | 3, 981 (10.1%) |
| Hispanic | 122 (22.1%) | 7,174 (18.2%) |
| Asian/Pacific Islander | 46 (8.3%) | 3,626 (9.2%) |
| Native American | 6 (1.1%) | 27 (0.07%) |
| Other | 0 | 741 (1.88%) |
| AHRQ comorbidity measures | ||
| Valvular heart disease | 63 (11.4%) | 3271 (8.3%) |
| Congestive heart failure | 124 (22.5%) | 5598 (14.2%) |
| Pulmonary circulation disorders | 23 (4.2%) | 1064 (2.7%) |
| Chronic pulmonary disease | 148 (26.8%) | 5598 (14.2%) |
| Coagulopathy | 29 (5.2%) | 1458 (3.7%) |
| Peripheral vascular disorders | 57 (10.3%) | 3744 (9.5%) |
| Hypertension | 433 (78.2%) | 31,419 (79.7%) |
| Diabetes with chronic complications | 66 (11.9%) | 3430 (8.7%) |
| Diabetes, uncomplicated | 145 (26.2%) | 10, 092 (25.6%) |
| Renal failure | 128 (23.1%) | 5992 (15.2%) |
| Alcohol abuse | 17 (3.0%) | 1616 (4.1%) |
| Obesity | 54 (9.7%) | 3430 (8.7%) |
| Drug abuse | 15 (2.8%) | 1025 (2.6%) |
| Weight loss | 43 (7.7%) | 1853 (4.7%) |
| Rheumatoid arthritis/collagen vascular diseases | 16 (2.9%) | 946 (2.4%) |
| Depression | 53 (9.6%) | 3232 (8.2%) |
| Other neurological disorders | 31 (5.7%) | 1380 (3.5%) |
| Paralysis | 40 (7.2%) | 2838 (7.2%) |
| Psychoses | 25 (4.6%) | 1498 (3.8%) |
| Solid Tumor without metastasis | 11 (2.1%) | 749 (1.9%) |
| Metastatic cancer | 7 (1.2%) | 631 (1.6%) |
| Lymphoma | 9 (1.6%) | 233 (0.59%) |
| Acquired immune deficiency syndrome | 1 (0.17%) | 59 (0.15%) |